Corpus ID: 75716000

The antiangiogenesis role of arsenic trioxide in acute myeloid leukemia

@article{Men2005TheAR,
  title={The antiangiogenesis role of arsenic trioxide in acute myeloid leukemia},
  author={Z. Men},
  journal={Journal of Clinical Internal Medicine},
  year={2005}
}
  • Z. Men
  • Published 2005
  • Medicine
  • Journal of Clinical Internal Medicine
Objection To explore antiangiogenesis role of Arsenic trioxide in Acute myeloid Leukemia(APL).Methods (1)ELISA was used to quality the level of vascular endothelial growth factor ( VEGF) in the supernatant of bone marrow monocyte nucleus cells (BMMNC) in APL patients before and after Arsenic trioxide treatment.(2)Annexin-Ⅴ Kit was used to detect the apoptosis cells by flow cytomery.The assay of bcl-2 protein expression was tested by FITC-conjugated hamster anti-human bcl-2 monoclonal antibody… Expand